NeoVista - Top 10 medical device VC deals, H1 2011

Company: NeoVista
Based: Newark, CA
Amount: $33M

Investors: Accuitive Medical Ventures, Carlyle Group, Essex Woodlands Health Ventures, MPM Capital, SV Life Sciences Advisers, and Versant Ventures

Scoop: NeoVista received backing for its efforts in the macular degeneration field from several previous investors. The new Series E round, valued at $33 million, was announced in February.

NeoVista's approach to macular degeneration differs from the norm, where injectables reign. Instead, the company uses an intraocular brachytherapy device, administering radiation to the choroidal vascular bed of the retina. The procedure has undergone three clinical trials, including one 500-patient Phase III trial, with some results still pending.

NeoVista - Top 10 medical device VC deals, H1 2011
Read more on